Home
Scholarly Works
Efficacy and safety of gefapixant for treatment of...
Conference

Efficacy and safety of gefapixant for treatment of refractory or unexplained chronic cough: a systematic review and dose-response meta-analysis

Authors

Kum E; Patel M; Diab N; Wahab M; Zeraatkar D; Chu D; Guyatt G; O'Byrne P; Satia I

Publisher

European Respiratory Society (ERS)

Publication Date

September 9, 2023

DOI

10.1183/13993003.congress-2023.pa3033

Name of conference

Airway pharmacology and treatment
View published work (Non-McMaster Users)

Contact the Experts team